cdk4 glutathione Discovery of the GSH responsive “Y-PROTACs” targeting ALK and CDK4/6 as a potential treatment for cancer CDK2 and CDK4: Cell Cycle
CDK2 and CDK4: Cell Cycle Functions Evolve Distinct, Catalysis Competent Conformations, Offering Drug Targets JACS Au reduced glutathione and breast cancer SLC7A11 protects luminal A breast cancer cells against ferroptosis induced by Nuclear glutathione cycle and associated redox changes during cell Download Scientific Diagram Targeting CDK4 6 for Anticancer Therapy Cyclin D Cdk4,6 drives cell cycle progression via the retinoblastoma protein's C terminal helix bioRxiv Cyclin D Cdk4,6 Drives Cell Cycle Progression via the Retinoblastoma Protein's C Terminal Helix PMC
Pay in 4 interest-free payments of $7.26 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7





